Docebo Inc.
NASDAQ:DCBOSoftware - Application
+$0.36 today
- Market cap
- $751.67M
- Beta
- 0.76
- P/E (TTM)
- 14.0
- EPS (TTM)
- $1.23
Volume 0.06M
Average 0.15M
DCBO Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Docebo Inc.NASDAQ: DCBO
Cost of Revenue · Q1 FY2026 · quarter ended Mar 2026
Cost of revenue growth accelerates
Q1 FY2026 cost of revenue of $14.35M rose 26.0% year over year, ahead of the +18.8% change in trailing-twelve-month cost of revenue. Sequentially, it rose 12.7% from the prior quarter. Over 3 fiscal years it compounded at +19.3% a year.
Context
- Cost of revenue amounted to 19.7% of revenue in FY2025, up 0.7 pp from a year earlier.
- Cost of revenue increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +26.0% holds above the trailing-twelve-month pace of +18.8%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
USD · from the income statement
- Latest · FY2025
- 47.85M USD
- Year-over-year change
- +15.9%
- 4-year CAGR
- +23.2%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 47.85M | +15.9% |
| FY2024 | 2024-12-31 | 41.3M | +19.7% |
| FY2023 | 2023-12-31 | 34.5M | +22.4% |
| FY2022 | 2022-12-31 | 28.18M | +35.6% |
| FY2021 | 2021-12-31 | 20.79M | — |
Cost of Revenue vs competitors
How DCBO compares with its peers on the latest reported figures
- DCBO's LTM Mar 2026 cost of revenue of $50.81M is the lowest of the 3 companies compared; the peer median is $109.91M.
- Its year-over-year change of +18.8% is the highest of 3, against a peer median of +11.1%.
- Cost of revenue amounts to 20.2% of revenue for DCBO, versus a peer median of 35.3%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Apr 2026 | $147.84M | +11.4% | -4.0% | 30.6% | |
| LTM Mar 2026 | $71.99M | +10.8% | +15.4% | 40.0% | |
| LTM Mar 2026 | $50.81M | +18.8% | +19.3% | 20.2% | |
| Peer median (excluding DCBO) | $109.91M | +11.1% | +5.7% | 35.3% | |
Competitors are the stored peer set for DCBO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 104.24M | 142.91M | 180.84M | 216.93M | 242.69M |
| Cost of Revenue | 20.79M | 28.18M | 34.5M | 41.3M | 47.85M |
| Gross Profit | 83.46M | 114.73M | 146.34M | 175.64M | 194.84M |
| Gross Margin | 80.1% | 80.3% | 80.9% | 81.0% | 80.3% |
| Research & Development | 20.36M | 24.78M | 35.48M | 43.91M | 50.12M |
| Selling, General & Admin | 74.05M | 94.55M | 107.04M | 109.44M | 117.05M |
| Operating Expenses | 96.91M | 110.55M | 150.05M | 156.73M | 170.36M |
| Depreciation & Amortization | 2.02M | 2.33M | 3.14M | 3.38M | 3.19M |
| EBITDA | (10.92M) | 10.49M | 8.28M | 27.28M | 27.78M |
| EBITDA Margin | -10.5% | 7.3% | 4.6% | 12.6% | 11.4% |
| Operating Income | (13.45M) | 4.19M | (3.71M) | 18.91M | 24.48M |
| Operating Margin | -12.9% | 2.9% | -2.1% | 8.7% | 10.1% |
| Interest Income | 433.15K | 3.76M | 8.11M | 2.55M | 1.86M |
| Interest Expense | 425.23K | 278.51K | 297.35K | 222.76K | 146K |
| Other Income / Expenses | 20K | 3.6M | 8.56M | 4.81M | (34K) |
| Income Before Tax | (13.43M) | 7.78M | 4.85M | 23.71M | 24.45M |
| Pre-Tax Margin | -12.9% | 5.4% | 2.7% | 10.9% | 10.1% |
| Income Tax Expense | 172K | 764K | 2.01M | (3.02M) | (13.07M) |
| Net Income | (13.6M) | 7.02M | 2.84M | 26.74M | 37.51M |
| Net Margin | -13.0% | 4.9% | 1.6% | 12.3% | 15.5% |
| EPS (Basic) | (0.41) | 0.20 | 0.09 | 0.88 | 1.33 |
| EPS (Diluted) | (0.41) | 0.20 | 0.08 | 0.86 | 1.30 |
| Weighted Avg Shares | 32.87M | 33.07M | 32.53M | 30.22M | 28.69M |
| Weighted Avg Shares (Diluted) | 32.87M | 34.04M | 33.68M | 30.94M | 29.37M |
Docebo Inc.
NASDAQ:DCBO
Intrinsic Alpha fair value
Locked
Current Price
$30.13
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.